Results of a secondary analysis of data from the ASPREE trial quantified the CVD burden for older adults after cancer and its treatment.

Researchers conducted a cross-sectional study to assess the prevalence of gender-affirming surgeries among transgender and gender-diverse children in the US.

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant improvement in overall survival ...

Researchers sought to determine whether high antimetabolite dose intensity is related to higher treatment-induced toxicity in pediatric patients with ALL.

Patients who received subcutaneous daratumumab plus bortezomib, lenalidomide, and dexamethasone (VRd) had better outcomes than patients who received VRd alone.